vs
AURORA CANNABIS INC（ACB）与biote Corp.（BTMD）财务数据对比。点击上方公司名可切换其他公司
biote Corp.的季度营收约是AURORA CANNABIS INC的492.7倍（$46.4M vs $94.2K）。biote Corp.净利率更高（4.2% vs -1.9%，领先6.1%）
奥罗拉大麻公司是加拿大获得官方许可的大麻生产商，总部位于埃德蒙顿。截至2018年9月，公司拥有八家合规生产工厂、五张销售牌照，业务遍及全球25个国家，年大麻产能超62.5万公斤，核心产能布局在加拿大，同时在丹麦、拉美等国际市场积极拓展业务。
biote Corp是一家专注于个性化生物同质性激素替代疗法的医疗企业，主要面向美国市场运营，为持牌医疗从业者提供相关培训课程，同时推出配套健康补剂与诊断服务，以提升患者诊疗效果。
ACB vs BTMD — 直观对比
营收规模更大
BTMD
是对方的492.7倍
$94.2K
净利率更高
BTMD
高出6.1%
-1.9%
损益表 — Q3 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $94.2K | $46.4M |
| 净利润 | $-1.7K | $2.0M |
| 毛利率 | — | — |
| 营业利润率 | — | 14.7% |
| 净利率 | -1.9% | 4.2% |
| 营收同比 | — | -6.9% |
| 净利润同比 | — | -47.2% |
| 每股收益（稀释后） | — | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACBBTMD
| Q4 25 | $94.2K | $46.4M | ||
| Q3 25 | — | $48.0M | ||
| Q2 25 | — | $48.9M | ||
| Q1 25 | $90.5K | $49.0M | ||
| Q4 24 | — | $49.8M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $49.2M | ||
| Q1 24 | $45.6K | $46.8M |
净利润ACBBTMD
| Q4 25 | $-1.7K | $2.0M | ||
| Q3 25 | — | $8.2M | ||
| Q2 25 | — | $3.2M | ||
| Q1 25 | — | $13.7M | ||
| Q4 24 | — | $3.7M | ||
| Q3 24 | — | $10.7M | ||
| Q2 24 | — | $-7.1M | ||
| Q1 24 | — | $-4.2M |
毛利率ACBBTMD
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 54.0% | — |
营业利润率ACBBTMD
| Q4 25 | — | 14.7% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 22.0% | ||
| Q1 25 | — | 19.8% | ||
| Q4 24 | — | 5.6% | ||
| Q3 24 | — | 23.7% | ||
| Q2 24 | — | 12.7% | ||
| Q1 24 | — | 22.3% |
净利率ACBBTMD
| Q4 25 | -1.9% | 4.2% | ||
| Q3 25 | — | 17.1% | ||
| Q2 25 | — | 6.5% | ||
| Q1 25 | — | 28.0% | ||
| Q4 24 | — | 7.4% | ||
| Q3 24 | — | 20.8% | ||
| Q2 24 | — | -14.4% | ||
| Q1 24 | — | -8.9% |
每股收益（稀释后）ACBBTMD
| Q4 25 | — | $0.05 | ||
| Q3 25 | — | $0.22 | ||
| Q2 25 | — | $0.10 | ||
| Q1 25 | — | $0.37 | ||
| Q4 24 | — | $0.09 | ||
| Q3 24 | — | $0.33 | ||
| Q2 24 | — | $-0.21 | ||
| Q1 24 | — | $-0.12 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $24.1M |
| 总债务越低越好 | — | $103.1M |
| 股东权益账面价值 | — | $-58.5M |
| 总资产 | — | $107.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ACBBTMD
| Q4 25 | — | $24.1M | ||
| Q3 25 | — | $28.0M | ||
| Q2 25 | — | $19.6M | ||
| Q1 25 | — | $41.7M | ||
| Q4 24 | — | $39.3M | ||
| Q3 24 | — | $38.2M | ||
| Q2 24 | — | $26.4M | ||
| Q1 24 | — | $78.8M |
总债务ACBBTMD
| Q4 25 | — | $103.1M | ||
| Q3 25 | — | $104.7M | ||
| Q2 25 | — | $106.3M | ||
| Q1 25 | — | $107.8M | ||
| Q4 24 | — | $109.4M | ||
| Q3 24 | — | $110.9M | ||
| Q2 24 | — | $112.5M | ||
| Q1 24 | — | $114.1M |
股东权益ACBBTMD
| Q4 25 | — | $-58.5M | ||
| Q3 25 | — | $-72.8M | ||
| Q2 25 | — | $-85.1M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $-105.9M | ||
| Q3 24 | — | $-130.3M | ||
| Q2 24 | — | $-143.2M | ||
| Q1 24 | — | $-36.0M |
总资产ACBBTMD
| Q4 25 | — | $107.6M | ||
| Q3 25 | — | $111.3M | ||
| Q2 25 | — | $104.8M | ||
| Q1 25 | — | $123.4M | ||
| Q4 24 | — | $122.4M | ||
| Q3 24 | — | $101.3M | ||
| Q2 24 | — | $92.9M | ||
| Q1 24 | — | $160.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $7.6M |
| 自由现金流经营现金流 - 资本支出 | — | $6.5M |
| 自由现金流率自由现金流/营收 | — | 14.0% |
| 资本支出强度资本支出/营收 | — | 2.3% |
| 现金转化率经营现金流/净利润 | — | 3.87× |
| 过去12个月自由现金流最近4个季度 | — | $30.2M |
8季度趋势，按日历期对齐
经营现金流ACBBTMD
| Q4 25 | — | $7.6M | ||
| Q3 25 | — | $14.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.5M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $15.6M | ||
| Q2 24 | — | $9.9M | ||
| Q1 24 | — | $7.4M |
自由现金流ACBBTMD
| Q4 25 | — | $6.5M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $5.3M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $10.7M | ||
| Q3 24 | — | $14.0M | ||
| Q2 24 | — | $7.4M | ||
| Q1 24 | — | $6.7M |
自由现金流率ACBBTMD
| Q4 25 | — | 14.0% | ||
| Q3 25 | — | 28.3% | ||
| Q2 25 | — | 10.8% | ||
| Q1 25 | — | 9.9% | ||
| Q4 24 | — | 21.5% | ||
| Q3 24 | — | 27.3% | ||
| Q2 24 | — | 15.1% | ||
| Q1 24 | — | 14.2% |
资本支出强度ACBBTMD
| Q4 25 | — | 2.3% | ||
| Q3 25 | — | 1.0% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 3.3% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 1.5% |
现金转化率ACBBTMD
| Q4 25 | — | 3.87× | ||
| Q3 25 | — | 1.72× | ||
| Q2 25 | — | 2.22× | ||
| Q1 25 | — | 0.47× | ||
| Q4 24 | — | 3.34× | ||
| Q3 24 | — | 1.45× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACB
暂无分部数据
BTMD
| Product Revenue | $45.3M | 98% |
| Disposable Trocars Product Revenue | $1.2M | 3% |
